ClinicalTrials.gov
ClinicalTrials.gov Menu

Anti-OX40, Cyclophosphamide (CTX) and Radiation in Patients With Progressive Metastatic Prostate Cancer

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
ClinicalTrials.gov Identifier: NCT01303705
Recruitment Status : Active, not recruiting
First Posted : February 25, 2011
Last Update Posted : June 15, 2017
Sponsor:
Collaborator:
MedImmune LLC
Information provided by (Responsible Party):
Providence Health & Services

No Study Results Posted on ClinicalTrials.gov for this Study
  Recruitment Status : Active, not recruiting
  Estimated Primary Completion Date : October 2018
  Estimated Study Completion Date : October 2020